you afternoon, much, so And Peter. everyone. Thank good
the developed an and since on after weeks. have and even Frankly, a employees technology few my team strength, consulting into of we’re a what firm the with spending and since Interim November highly as forward. May President of our and and I’ve now served its appreciation XXXX CEO, significant outside Having company’s encouraged going role a just with conduct time Board hard Directors seen rigorous by capable talented of Sera’s advisers and evaluation leading past I weeks business at I’m few these working of strategic to our achieving greater what
time, today Mindful accelerate and strategic and my priorities fact vision, short date and I’ve key revenue adoption I longer-term our midterm, been to the of role learnings the map. of test of strategic to focus on aspects in in comments well that most the a road Sera’s will key as as near
pioneered pregnancy Sera will into in the new risk we is a of and a PreTRM continuous blood in draw-based to test our unique mark unique in usher believe to birth. This determine PreTRM, we’re process predictors set. many set building risk yield actionable exploring. potentially of as of other XX,XXX time anticipate more We we and birth a nearly to compiled complications this as well unique and data development care. what of commercialization position In data data strong of tests the era pregnancy preeclampsia improved and should pregnancy provides to prognostic have PreTRM like continue accurate pregnancies insights
value commercially vision fulfill As creation and valuable be the us the we company. our this as will I’ll on momentarily, help be well touch to data as believe pregnancy support shareholder longer-term
this in scaling commercial payers, also truly takes medical the data patient offering build-out. and to a date test impact costs. and we’re community the we’ve learned still of such save have patients care provides save health novel as that care on What an is can PreTRM among lives it our learned time, well early commercializing We’ve through stages that the and as
established business essential towards What valuation treatment rigorous market will our commercial last These effectiveness, evident to weeks, over to and the growing test coverage even better success. lend payer for test our few anticipate which finally, more have illustrating outcomes, method. and adoption positioning we awareness and are successful study is standard-of-care revenue publications Sera essentials and become itself
of available. To most sharing publication, presented already submitted recent date, forward compelling to we become TRIAL, we’ve we’re excited share a for the our once And AVERT they data and data. to recently, look from publicly was manuscript results which
results endpoints: However, new met do the we two our neonatal as natal health. reduced show that of and improved announced in primary length February, stay
course. in care be a detailed published due AVERT an cost particularly growing infants. expect of born prematurely results medical institution babies value given and to NICU in to when peer-reviewed obviously complications. as the journal with We Sera see for keep one during babies outcomes ten doctors long-term of And and mothers will care better the want of patients are prematurely health of see safe pregnancy and born out
study know so we’ve clinical what to informed approved specific guidelines. follow standard standard and stakeholders, treat supporting can said, of that the works, patients, evidence they and care what establishment test need with care of that along also the of is to noted doctors approach of This That the guidelines. all requires the show particularly is
treatment regards in, best results in test the no once are to forward. there’s path the So, guesswork
establish to we guidelines, place the in support why of We and and need our business these effectively. is standard actions take success of takes of But the need for which business to establishment to refocus believe PreTRM awareness time, our of we better optimize cost several already market essentials. have care
balance We are undertaking this effort protecting strong diligently, while carefully our sheet.
institutions data year; two, launching that these evidence value pilot and near-term real-world the PreTRM. studies coordination with quickly in thus revenue and care initiating focus opportunities? are of identified offering; include: our during midterm first, reengaging out of engaging improve more we bringing see this far activate We one, as So, Number levers revenues. three an what to to near increased we the key points evaluation our new of illustrating extending the have three,
in subjects outcomes The neonatal example, values. lower the to neonatal in for screen-positive For screened low-dose PreTRM AVERT associated stay that demonstrated peer with group the and controls. in test morbidity prolonged and significantly sub-analysis of reduction was length pregnancy that review manuscript present pregnancy aspirin. submitted interventions been has and were the management compared tests care show with In PreTRM included prolongation the
Additionally, we can of birth a we’re treat see been in of provide. their to to studied study, populations, strategy to have deciding the and we aiming using test outcomes who in racially PreTRM in evidence waiting now population, which more and diverse additional effectiveness our particular, diverse bring in the customers impact
identified test after significant additional coordination next in trend we twelve care physicians birth using the to PreTRM the the PreTRM versus risk expect a to pilot their as physicians women as coordination for of quickly service We’re pilot for to a test. level pilot as orders high-risk the we in launching In process quarter a positive high institutions patients program in pilot increasing the this, believe to to comfort months. extend who test to the by six resulted provide by launch quarter the our of address We cannot before. care the hurdle adoption can patients. offering can for offering This view of in
real-world to aiming additional expand evidence we’re and via studies. generation third, our evidence activities And commercialization
randomized the launch be realized. in that more to least coming outcomes two of and six trials to replicated goal controlled show aiming Our is studies years the next at can in months, for
engaging with leading this large, We in us institutions work. are recognized, nationally to partner
to are of value As believe commercial proposition efforts, educate also with can investment a value Sera not broader we PreTRM. to of but stronger and the our achieve familiar these on revenue from already result and a who a and key set of physicians willing use leaders ROI clinicians we are growth only opinion other test the higher and
multiple through reviewing five-year This opportunities in levers, revenue bringing such penetration on additional successfully entail as to value This the approach our include our margin options portfolio. additional these ramping States paid vision beyond points. and such more market in price current currently platform United potentially pregnancy for those well enhancing also PreTRM approaches development a we’re broadening as would by to our streams litigious physicians term, and beyond pipeline as that. products our and wholesome market care executing exploring as patient globally, calls proposition would a Longer as where up developing
a sheet patients, or PreTRM balance to or product acquisition plan complementary broaden also our to may company be growth. new clinicians to structure. fashion with and driving in disciplined accretive potentially overextending Launching explore highly targets capital products relationships We while which could us not the revenue to allow boost also
excited potential launch to and monetize about is vision, our strategy. we’re regards the rather something longer our to in data-is-an-asset Finally, and term
day range data XX,XXX by analytics set on the opportunity we the use care pregnancies of of date and to issues to a a growing our compelling in broad Here, breakthroughs proteomics using create partner nearly pregnancy. of across high-value in see day and predictive to
as complications, to Ultimately diabetes date, such in addition preeclampsia pregnancy to preterm profiled birth. and we’ve many important gestational
these and utility as human With identifying within with If health opportunities which from approach technologies options. leveraging through we the we health demographic early assay. them data-driven proprietary infancy as integrate sets, data insights, capability believe clinical powerful our data and this we to Combined, in provides have for high-margin potentially anticipate Sera’s could and executed and licensing revenue possibly insights complementary better well, from pregnancy care possible even on then up other this management. and open technologies significant products partnering issues
update call you the hand our let me over Austin, to on I PRIME study. a moment take Before to
As X,XXX. analysis the at subject and has over to interim enrollment the noted enrolled last now trial PRIME required be in surpassed more to occur for subjects X,XXX quarter, study than stands look
August, interim We hospital we’re requires study continue PRIME the final prior mothers of timing data to look followed by for discharge the end to of completed of then analysis the to by results. the be and event babies, and the deliveries get the excited of potential and looking about really cleanup this delivery,
increased the learnings, need the as we to given for not year, seeing to of we by results though translate earlier, about end into the guidelines test look the interest be We excited a are for noted and adoption immediately those given follow. I may forward mindful defined although physicians they accelerated may key standard-of-care
proven we bundle PRIME That to our up change We established to course delivery be yield testing community the health completed. PRIME problems that of an now medical of volumes would the standard in levered help and has is more treatment care after once could been for to benefits. would order premature with have demonstrably, the action positive guidelines in mitigate favor said, are expect accepted
coordination patients, our to planned as as And and Moving forward, possible. pilot through establish be help would my physician activities a going back determine data program engage factors earlier to advantaged to of on be our best. other our do comments guidelines may care and there pregnancy we care soon to leveraging on and to plan physicians our based which care recommendations vision, intervention risk sets made future where likelihood be proven for five-year to could the work in part
I’ll now for results. to financial second over of turn a the review Austin call our quarter Austin?
